Reactive thrombocytosis might contribute to chemotherapy-related thrombophilia in patients with lung cancer.


PURPOSE Thrombotic risk is increased in patients with cancer and further potentiated by chemotherapy. We assessed whether early hemostatic alterations could represent a risk factor for thrombosis in patients undergoing chemotherapy for lung cancer. PATIENTS AND METHODS Forty-nine patients receiving chemotherapy for unresectable, locally advanced, or… (More)


  • Presentations referencing similar topics